|
MCID: PYD001
|
Pyoderma Gangrenosum malady |
|
Sources: 30NIH Rare Diseases, 44Wikipedia, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Pyoderma gangrenosum is a rare, destructive inflammatory skin disease of which a painful nodule or pustule breaks down to form a progressively enlarging ulcer. Lesions may occur either in the absence of any apparent underlying disorder or in association with other diseases, such as ulcerative colitis, Crohn's disease, polyarthritis (an inflammation of several joints together), gammopathy, and other conditions . Pyoderma gangrenosum belongs to a group of skin diseases in which a common cellular denominator is the neutrophil. Neutrophils are a type of white blood cell or leukocyte which form an early line of defense against bacterial infections. Each year in the United States, pyoderma gangrenosum occurs in about 1 person per 100.000 people.30
MalaCards: Pyoderma Gangrenosum, also known as pyoderma gangrenosum (disorder), is related to pyogenic arthritis, pyoderma gangrenosum and acne and arthritis. An important gene associated with Pyoderma Gangrenosum is PSTPIP1 (proline-serine-threonine phosphatase interacting protein 1), and among its related pathways are Immune response_Bacterial infections in normal airways and Immune System. The drugs clofazimine and sulfapyridine and the compounds cyclophosphamide and epinephrine have been mentioned in the context of this disorder. Affiliated tissues include skin and monocytes, and related mouse phenotypes are hematopoietic system and skeleton. Wikipedia: Pyoderma gangrenosum is a condition that causes tissue to become necrotic, causing deep ulcers that...44 more... |
|
Sources: 6Disease Ontology, 30NIH Rare Diseases, 8DISEASES, 32Novoseek , 43UMLS, 24MeSH, 40SNOMED-CT, 19ICD9CM See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for pyoderma gangrenosum Drug clinical trials:Search ClinicalTrials for pyoderma gangrenosum Search NIH Clinical Center for pyoderma gangrenosum Search CenterWatch for pyoderma gangrenosum Inferred drug relations via UMLS/NDF-RT:43 28 clofazimine, sulfapyridine |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to pyoderma gangrenosum:22Skin, Monocytes
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to pyoderma gangrenosum:25
|
|
Sources: 35PubMed See all sources |
Articles related to pyoderma gangrenosum:(show all 23)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 41Thomson Reuters, 38Reactome, 36QIAGEN, 10EMD Millipore, 20KEGG See all sources |
Pathways related to pyoderma gangrenosum according to GeneDecks:(show all 35)
|
|
Sources: 32Novoseek , 34PharmGKB, 9DrugBank, 18HMDB, 42Tocris Bioscience See all sources |
Compounds related to pyoderma gangrenosum according to GeneDecks:(show top 50) (show all 120)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to pyoderma gangrenosum according to GeneDecks:
Biological processes related to pyoderma gangrenosum according to GeneDecks:(show all 11)
Molecular functions related to pyoderma gangrenosum according to GeneDecks:
|
